theres only 3 companies that produce it , Eli Lily, sanofi aventis and novo nordisk, they have fought aggressively through litigation in the past to prevent any insulin generic, or biosimilar to reach the market. they agreed amongst themselves to have whatever the cost they want without competing with each other.
this kind of thing scales well, i see no reason why after california has it set up, other states couldn’t get insulin from them, or chip in
I would think Big Pharma will aggressively fight against it.
theres only 3 companies that produce it , Eli Lily, sanofi aventis and novo nordisk, they have fought aggressively through litigation in the past to prevent any insulin generic, or biosimilar to reach the market. they agreed amongst themselves to have whatever the cost they want without competing with each other.
Civica is launching insulin glargine in early 2026 specifically because of that bullshit.
good. generic biosimilars cost like 1/5 of the on-patent thing price
deleted by creator
deleted by creator